1. Home
  2. GRBK vs JANX Comparison

GRBK vs JANX Comparison

Compare GRBK & JANX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GRBK
  • JANX
  • Stock Information
  • Founded
  • GRBK 2006
  • JANX 2017
  • Country
  • GRBK United States
  • JANX United States
  • Employees
  • GRBK N/A
  • JANX N/A
  • Industry
  • GRBK Homebuilding
  • JANX Biotechnology: Pharmaceutical Preparations
  • Sector
  • GRBK Consumer Discretionary
  • JANX Health Care
  • Exchange
  • GRBK Nasdaq
  • JANX Nasdaq
  • Market Cap
  • GRBK 2.6B
  • JANX 2.2B
  • IPO Year
  • GRBK N/A
  • JANX 2021
  • Fundamental
  • Price
  • GRBK $57.72
  • JANX $36.01
  • Analyst Decision
  • GRBK Hold
  • JANX Strong Buy
  • Analyst Count
  • GRBK 3
  • JANX 11
  • Target Price
  • GRBK $65.50
  • JANX $83.09
  • AVG Volume (30 Days)
  • GRBK 243.5K
  • JANX 821.6K
  • Earning Date
  • GRBK 02-26-2025
  • JANX 03-07-2025
  • Dividend Yield
  • GRBK N/A
  • JANX N/A
  • EPS Growth
  • GRBK 34.39
  • JANX N/A
  • EPS
  • GRBK 7.71
  • JANX N/A
  • Revenue
  • GRBK $1,982,011,000.00
  • JANX $13,049,000.00
  • Revenue This Year
  • GRBK $19.54
  • JANX $39.66
  • Revenue Next Year
  • GRBK $9.88
  • JANX N/A
  • P/E Ratio
  • GRBK $7.50
  • JANX N/A
  • Revenue Growth
  • GRBK 12.72
  • JANX 54.12
  • 52 Week Low
  • GRBK $50.67
  • JANX $14.68
  • 52 Week High
  • GRBK $84.66
  • JANX $71.71
  • Technical
  • Relative Strength Index (RSI)
  • GRBK 42.04
  • JANX 34.78
  • Support Level
  • GRBK $58.19
  • JANX $36.13
  • Resistance Level
  • GRBK $61.82
  • JANX $38.13
  • Average True Range (ATR)
  • GRBK 1.52
  • JANX 2.52
  • MACD
  • GRBK -0.08
  • JANX 0.08
  • Stochastic Oscillator
  • GRBK 6.39
  • JANX 5.71

About GRBK Green Brick Partners Inc.

Green Brick Partners Inc is a homebuilding and land development company. It acquires and develops land, as well as provides land and construction financing to its controlled builders. The company has three reportable segments: builder operations central, builder operations southeast, and land development. The majority of the company's revenue is generated from the builder operations central segment which is entirely the operations of builders in Texas. The company is engaged in various aspects of the homebuilding process, including land acquisition and development, entitlements, design, construction, marketing, sales, and brand image creation. In addition to homebuilding, the company provides home financing services, such as mortgage and title, through its subsidiaries.

About JANX Janux Therapeutics Inc.

Janux Therapeutics Inc is a clinical-stage biopharmaceutical company developing next-generation therapeutics based on proprietary tumor activated T Cell Engager platform technology to treat patients suffering from cancer.

Share on Social Networks: